ATE157666T1 - Verfahren zur selektiven herstellung von hydratkristallen - Google Patents

Verfahren zur selektiven herstellung von hydratkristallen

Info

Publication number
ATE157666T1
ATE157666T1 AT91103032T AT91103032T ATE157666T1 AT E157666 T1 ATE157666 T1 AT E157666T1 AT 91103032 T AT91103032 T AT 91103032T AT 91103032 T AT91103032 T AT 91103032T AT E157666 T1 ATE157666 T1 AT E157666T1
Authority
AT
Austria
Prior art keywords
methyl
selective production
hydrate crystals
benzoxazine
pyrido
Prior art date
Application number
AT91103032T
Other languages
German (de)
English (en)
Inventor
Yukio Sato
Atsushi Sato
Tatsuro Sumikawa
Tazuo Uemura
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE157666T1 publication Critical patent/ATE157666T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT91103032T 1990-03-01 1991-02-28 Verfahren zur selektiven herstellung von hydratkristallen ATE157666T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5045490 1990-03-01

Publications (1)

Publication Number Publication Date
ATE157666T1 true ATE157666T1 (de) 1997-09-15

Family

ID=12859314

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91103032T ATE157666T1 (de) 1990-03-01 1991-02-28 Verfahren zur selektiven herstellung von hydratkristallen

Country Status (13)

Country Link
US (1) US5545737A (enExample)
EP (1) EP0444678B1 (enExample)
KR (1) KR970000045B1 (enExample)
AT (1) ATE157666T1 (enExample)
DE (1) DE69127485T2 (enExample)
ES (1) ES2106739T3 (enExample)
GR (1) GR3025276T3 (enExample)
HK (1) HK1002730A1 (enExample)
IE (1) IE910692A1 (enExample)
IN (1) IN172207B (enExample)
PT (1) PT96917B (enExample)
TW (1) TW208013B (enExample)
YU (1) YU48328B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
US7425628B2 (en) 2001-10-03 2008-09-16 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin
PT1451194E (pt) * 2001-10-03 2007-01-31 Teva Pharma Preparação de hemi-hidrato de levofloxacina
AU2002365416A1 (en) * 2001-11-29 2003-06-10 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin
AU2003285625A1 (en) * 2002-12-16 2004-07-09 Ranbaxy Laboratories Limited Pure levofloxacin hemihydrate and processes for preparation thereof
KR100704641B1 (ko) * 2004-07-21 2007-04-06 주식회사유한양행 고순도의 레보플록사신 제조방법
WO2006030452A1 (en) * 2004-09-17 2006-03-23 Matrix Laboratories Ltd An improved process for the preparation of levofloxacin hemihydrate
US20070244318A1 (en) * 2004-11-08 2007-10-18 Rao Davuluri R Process for the Preparation of Levofloxacin Hemihydrate
ES2255871B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la obtencion de levofloxacino exento de sales.
CN1321121C (zh) * 2005-04-21 2007-06-13 浙江医药股份有限公司新昌制药厂 左氧氟沙星制备及后处理方法
US7964723B2 (en) * 2008-08-02 2011-06-21 Apeloa-Kangyu And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate
CN101863904A (zh) * 2010-07-08 2010-10-20 浙江东亚药业有限公司 一种高纯度左氧氟沙星半水合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE203719C (enExample) * 1907-11-02 1908-10-20
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS57131769A (en) * 1981-02-10 1982-08-14 Kissei Pharmaceut Co Ltd 4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate, its preparation and drug containing the same
JPS5843977A (ja) * 1981-09-09 1983-03-14 Dai Ichi Seiyaku Co Ltd ピリドベンズオキサジン誘導体の製法
JPS60226855A (ja) * 1984-04-26 1985-11-12 Nippon Kayaku Co Ltd N−ベンジルオキシカルボニル−l−スレオニンアミド・1/2水和物およびその製造法
DK170473B1 (da) * 1985-06-20 1995-09-11 Daiichi Seiyaku Co S(-)-pyridobenzoxazinforbindelser
ZA864518B (en) * 1985-06-20 1987-03-25 Daiichi Seiyaku Co Optically active pyridobenzoxazine derivatives and intermediates thereof
MY104139A (en) * 1988-08-09 1994-02-28 Daiichi Seiyaku Co Antimicrobial agent for animals
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate

Also Published As

Publication number Publication date
PT96917A (pt) 1991-10-31
US5545737A (en) 1996-08-13
ES2106739T3 (es) 1997-11-16
TW208013B (enExample) 1993-06-21
KR970000045B1 (ko) 1997-01-04
DE69127485T2 (de) 1998-04-02
HK1002730A1 (en) 1998-09-11
IE910692A1 (en) 1991-09-11
KR910016748A (ko) 1991-11-05
PT96917B (pt) 1998-07-31
YU48328B (sh) 1998-05-15
GR3025276T3 (en) 1998-02-27
EP0444678A1 (en) 1991-09-04
YU35491A (sh) 1994-04-05
EP0444678B1 (en) 1997-09-03
IN172207B (enExample) 1993-05-01
DE69127485D1 (de) 1997-10-09

Similar Documents

Publication Publication Date Title
ATE157666T1 (de) Verfahren zur selektiven herstellung von hydratkristallen
DE3673908D1 (de) Verfahren zur herstellung eines mikroporoesen polyaethylenfilms.
ATE87540T1 (de) Verfahren und vorrichtung zur herstellung von polymermaterial.
DE69636818D1 (de) Verfahren zur selbst-justierten Herstellung von implantierten Gebieten
HU9603072D0 (en) Stabile cristalline salts of tetrahydrofolic acid
KR840007878A (ko) 벤조퀴놀리진 카르복실산 유도체의 제조방법
DE69110765D1 (de) Verfahren zur Herstellung isolierender Hourdisstein-Schalkörper, Vorrichtung zur Durchführung des Verfahrens und danach erhaltene Hourdissteine.
DE69319296D1 (de) Verfahren zur Reinigung von roher Clavulansäure
ATE205498T1 (de) Verfahren zur herstellung von kaliumclavulanat
DE69132091D1 (de) Verfahren zur Herstellung von Indolderivaten
ATE233751T1 (de) Verfahren zur herstellung und zwischenprodukt der 2-(10,11-dihydro-10-oxodibenzo(b,f)thiepin-2-yl - propionsäure
ATE20730T1 (de) Verfahren und vorrichtung zur biologischen nitrifikation von abwasser.
ATA112388A (de) Verfahren zur herstellung von 5-chlor-3chlorsulfonyl-2-thiophencarbonsaeureestern
DE59205377D1 (de) Mikrobiologisches Verfahren zur Herstellung von 5-Hydroxypyrazincarbonsäure
ATE156129T1 (de) Verfahren zur herstellung von kristallisiertem loracarbef monohydrat
ATE121746T1 (de) Verfahren zur herstellung bissilylierter 3- iodmethylcephalosporinderivaten.
DE3662780D1 (en) Process for the manufacture of dense anhydrous sodium carbonate, and dense anhydrous sodium carbonate obtained by this process
ATE146785T1 (de) Verfahren zur herstellung von diltiazem
EP0075473A3 (en) Selective acylation of hydroxy-amino-arylsulfonic acids
DE69111835D1 (de) Hydroxycarbonylderivate und Verfahren zu ihrer Herstellung.
ATE156824T1 (de) Verfahren zur herstellung von pyrido(1,2- a>pyrimidinderivaten
YU188086A (en) Process for obtaining 9-fluor-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido/1,2,3-de/-1,4-benzoxazine-6-carboxilic acid
ES466054A1 (es) Procedimiento de preparacion de compuestos del acido amino- espiro(oxa(o tia)cicloalcano-penam)-carboxilico
DE69421606D1 (de) Verfahren zur Herstellung von bipolaren Transistoren mit kontrollierter Speicherzeit
DE3764457D1 (de) Empfaengnisverhuetende, waessrig-saure zusammensetzung und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time